As big drug companies line up to announce new U.S. jobs and plants in the face of Trump tariff threats, generics giant Sandoz ...

An Enbrel biosim could save the U.S. about $1 billion per year, according to Sandoz. RELATED: With Enbrel patent victory, Amgen scores major win against biosims—and Sandoz takes a big loss ...

The U.S. Food and Drug Administration (FDA)- and the European Medicines Agency (EMA)- recommended dose for ENBREL for the treatment of moderate to severe RA is 50mg QW.

Amgen has announced that the U.S. Food and Drug Administration (FDA) has accepted for review their supplemental Biologics License Application (sBLA) for the expanded use of Enbrel (etanercept), to ...

The Food and Drug Administration (FDA) has approved Erelzi (etanercept-szzs; Sandoz) injection, a biosimilar to Enbrel (etanercept; Amgen). Erelzi is indicated for the treatment of moderate to ...

U.S. Food and Drug Administration (FDA) has approved ENBREL (etanercept) to treat people with psoriatic arthritis. ENBREL is the first therapy to receive approval to reduce the signs and symptoms ...

Oct. 14, 2004 — The U.S. Food and Drug Administration (FDA) has approved caspofungin acetate for the empiric treatment of presumed fungal infections in the setting of febrile neutropenia ...